Rodgers Brothers’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-57,680
| Closed | -$718K | – | 181 |
|
|
2016
Q4 | $718K | Sell |
57,680
-800
| -1% | -$9.63K | 0.28% | 80 |
|
|
2016
Q3 | $801K | Sell |
58,480
-500
| -0.8% | -$5.02K | 0.32% | 73 |
|
|
2016
Q2 | $436K | Hold |
58,980
| – | – | 0.18% | 106 |
|
|
2016
Q1 | $377K | Sell |
58,980
-500
| -0.8% | -$2.8K | 0.16% | 107 |
|
|
2015
Q4 | $372K | Hold |
59,480
| – | – | 0.17% | 102 |
|
|
2015
Q3 | $347K | Sell |
59,480
-500
| -0.8% | -$3.85K | 0.17% | 103 |
|
|
2015
Q2 | $496K | Buy |
59,980
+2,200
| +4% | +$19.5K | 0.23% | 89 |
|
|
2015
Q1 | $476K | Sell |
57,780
-2,500
| -4% | -$18.5K | 0.23% | 93 |
|
|
2014
Q4 | $414K | Sell |
60,280
-5,500
| -8% | -$34.4K | 0.21% | 96 |
|
|
2014
Q3 | $355K | Sell |
65,780
-800
| -1% | -$4.67K | 0.19% | 106 |
|
|
2014
Q2 | $424K | Hold |
66,580
| – | – | 0.21% | 101 |
|
|
2014
Q1 | $537K | Hold |
66,580
| – | – | 0.26% | 84 |
|
|
2013
Q4 | $454K | Buy |
66,580
+15,150
| +29% | +$81.8K | 0.23% | 88 |
|
|
2013
Q3 | $946K | Buy |
51,430
+1,600
| +3% | +$31.1K | 0.52% | 54 |
|
|
2013
Q2 | $872K | Buy |
+49,830
| New | +$883K | 0.52% | 53 |
|
Other funds holding ARIA
Rodgers Brothers's ARIA Position: Q1 2017 in Review
Rodgers Brothers sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 57,680 shares — an estimated $718K sold.
Rodgers Brothers first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $946K in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Rodgers Brothers reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Rodgers Brothers sold 57,680 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $718K.
- Rodgers Brothers first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
- Rodgers Brothers's Ariad Pharmaceuticals Inc position peaked at $946K in Q3 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Rodgers Brothers's 13F filing for Q1 2017, filed 15 May 2017.